We are pleased to announce a new partnership with Every Cure. Every Cure is a U.S.-based nonprofit on a mission to save and improve lives by repurposing drugs; the organization leverages AI to uncover new uses for existing medicines to address diseases with high unmet need. They validate the most promising opportunities through laboratory research and clinical studies, when necessary, and work to ensure that effective treatments reach patients as quickly as possible.
This collaboration brings together two mission-aligned organizations united by a shared commitment to making treatments more accessible and the belief that openness and collaboration are essential to getting there. By combining Conscience’s network and funding mechanisms (through the Developing Medicines through Open Science and Open Science Advisory Services programs) with Every Cure’s expertise and track-record in identifying promising medicine–disease matches, we will work together to find and co-fund projects to bring repurposed treatments to patients faster.
Drug repurposing is one of the most impactful ways to reduce time, cost, and risk in bringing new treatments to patients, especially for diseases that are underfunded or overlooked. Every Cure uses several AI-powered approaches to create a ranked list of repurposing opportunities including knowledge-graph-based, LLM-based, and real-world evidence-based approaches. They are actively pursuing nine repurposing programs across a range of conditions, from ultrarare to more common, all with high unmet medical needs. Every Cure’s co-founder and president, Dr. David Fajgenbaum, has previously identified and advanced 14 repurposed treatments, including one that saved his own life and others with his disease. Every Cure builds on that foundation of expertise to help more patients worldwide through scalable, AI-driven discovery and collaboration.
Every Cure’s efforts are well aligned with Conscience’s mission to enable drug discovery and development of new medicines in Canada through collaboration and open science. Through this partnership, we will identify cross-border projects that are both scientifically promising and mission-aligned, leveraging Conscience’s growing network of Canadian experts, research organizations, and CROs to find the right collaborators to help advance these projects. Together, we aim to build collaborations that bring the best of both sides of the border to accelerate new treatments for patients.
If you are a Canadian researcher or company with an idea for repurposing a drug, or you are interested in being part of a repurposing project, please contact Conscience. We want to hear from you.
For more information, please reach out to [email protected] or visit everycure.org.
